Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a Children's Oncology Group, multicentre, phase 3 trial-Reference-Cited by-同舟云学术

Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a Children's Oncology Group, multicentre, phase 3 trial

Published:2019-05 Issue:5 Volume:20 Page:719-727
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Katzenstein Howard M,Langham Max R,Malogolowkin Marcio H,Krailo Mark D,Towbin Alexander J,McCarville Mary Beth,Finegold Milton J,Ranganathan Sarangarajan,Dunn Stephen,McGahren Eugene D,Tiao Gregory M,O'Neill Allison F,Qayed Muna,Furman Wayne L,Xia Caihong,Rodriguez-Galindo Carlos,Meyers Rebecka L

Funder

Chair's

Statistics and Data Center

Imaging and Radiation Oncology Core

Publisher

Elsevier BV

Subject

Oncology

Reference16 articles.

1. Chemotherapeutic approaches for newly diagnosed hepatoblastoma: past, present, and future strategies;Trobaugh-Lotrario;Pediatr Blood Cancer,2012

2. Hepatoblastoma state of the art: pre-treatment extent of disease, surgical resection guidelines and the role of liver transplantation;Meyers;Curr Opin Pediatr,2014

3. Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: a report from the Children's Cancer Group and the Pediatric Oncology Group;Ortega;J Clin Oncol,2000